XDONSYA

Serial Number 87556015
Registration 5635674
700

Registration Progress

Application Filed
Aug 4, 2017
Under Examination
Approved for Publication
Oct 9, 2018
Published for Opposition
Oct 9, 2018
Registered
Dec 25, 2018

Basic Information

Serial Number
87556015
Registration Number
5635674
Filing Date
August 4, 2017
Registration Date
December 25, 2018
Published for Opposition
October 9, 2018
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 25, 2018
Registration
Registered
Classes
005

Rights Holder

Kissei Pharmaceutical Co., Ltd.

03
Address
19-48, Yoshino, Matsumoto-shi
Nagano 399-8710
JP

Ownership History

Kissei Pharmaceutical Co., Ltd.

Original Applicant
03
Nagano 399-8710 JP

Kissei Pharmaceutical Co., Ltd.

Owner at Publication
03
Nagano 399-8710 JP

Kissei Pharmaceutical Co., Ltd.

Original Registrant
03
Nagano 399-8710 JP

Legal Representation

Attorney
Robert B.G. Horowitz,
USPTO Deadlines 2 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
MAINTENANCE
Section 8 (6-Year) Declaration Due (Based on registration date 2018-12-25)
R.PRA Dec 25, 2024 194 days overdue Critical No
MAINTENANCE
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-12-25)
R.PRA Dec 25, 2028 1267 days Critical No
Next deadline: Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-12-25) on December 25, 2028 (1267 days)

Application History

22 events
Date Code Type Description
Dec 25, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 25, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER
Oct 16, 2018 ISPO Z WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Oct 16, 2018 1.BD I Sec. 1(B) CLAIM DELETED
Oct 11, 2018 D1BR I TEAS DELETE 1(B) BASIS RECEIVED
Oct 9, 2018 PUBO A PUBLISHED FOR OPPOSITION
Oct 9, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 19, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 5, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2018 CNSL R SUSPENSION LETTER WRITTEN
Jun 4, 2018 GNSL S LETTER OF SUSPENSION E-MAILED
Jun 4, 2018 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 15, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 9, 2018 ALIE A ASSIGNED TO LIE
May 3, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2017 CNRT R NON-FINAL ACTION WRITTEN
Nov 6, 2017 GNRT F NON-FINAL ACTION E-MAILED
Nov 6, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 31, 2017 DOCK D ASSIGNED TO EXAMINER
Aug 9, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2017 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for diagnostic purposes, treatment and prevention of endometriosis, uterine fibroids and other disorders of the reproductive system, of hormonally dependent conditions, and of inflammatory and immune system disorders
First Use Anywhere: 0
First Use in Commerce: 0

Active Deadlines

Section 8 (6-Year) Declaration Due (Based on registration date 2018-12-25)
Due: Dec 25, 2024 Overdue
Grace Period Until: Jun 25, 2025
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-12-25)
Due: Dec 25, 2028
Grace Period Until: Jun 25, 2029

Additional Information

Translation
"XDONSYA" has no meaning in a foreign language.

Classification

International Classes
005